Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Barrowman, Jemima ^a   Hamblet, Corinne ^a   Kane, Megan S ^a   Michaelis, Susan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LAMIN A; METALLOPROTEINASE; PRELAMIN A; PROTEIN ZMPSTE24; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; NUCLEAR PROTEIN; PROTEIN PRECURSOR; ZMPSTE24 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN 3T3; CELL STRAIN HEK293; CONTROLLED STUDY; MOUSE; MUTAGENESIS; MUTATION; NONHUMAN; PLASMID; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; FIBROBLAST; GENETICS; HUMAN; KIDNEY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PHYSIOLOGY; PREMATURE AGING; PROTEIN PRENYLATION; SEQUENCE HOMOLOGY;

AGING, PREMATURE; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; FIBROBLASTS; HUMANS; KIDNEY; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; PLASMIDS; PROTEIN PRECURSORS; PROTEIN PRENYLATION; PROTEOLYSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84857099433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032120     Document Type: Article

References (49)

1. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, et al. (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300: 2055.
2. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, et al. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423: 293-298.
3. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL, (2005) The nuclear lamina comes of age. Nat Rev Mol Cell Biol 6: 21-31.
4. Dittmer TA, Misteli T, (2011) The lamin protein family. Genome Biol 12: 222.
5. Davies BS, Fong LG, Yang SH, Coffinier C, Young SG, (2009) The posttranslational processing of prelamin A and disease. Annu Rev Genomics Hum Genet 10: 153-174.
6. Barrowman J, Hamblet C, George CM, Michaelis S, (2008) Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment. Mol Biol Cell 19: 5398-5408.
7. Wright LP, Philips MR, (2006) Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res 47: 883-891.
8. Schmidt WK, Tam A, Fujimura-Kamada K, Michaelis S, (1998) Endoplasmic reticulum membrane localization of Rce1p and Ste24p, yeast proteases involved in carboxyl-terminal CAAX protein processing and amino-terminal a-factor cleavage. Proc Natl Acad Sci U S A 95: 11175-11180.
9. Beck LA, Hosick TJ, Sinensky M, (1990) Isoprenylation is required for the processing of the lamin A precursor. J Cell Biol 110: 1489-1499.
10. Weber K, Plessmann U, Traub P, (1989) Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina. FEBS Lett 257: 411-414.
11. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, et al. (2002) Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31: 94-99.
12. Bergo MO, Gavino B, Ross J, Schmidt WK, Hong C, et al. (2002) Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci U S A 99: 13049-13054.
13. Young SG, Fong LG, Michaelis S, (2005) Prelamin A, Zmpste24, misshapen cell nuclei, and progeria-new evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res 46: 2531-2558.
14. Barrowman J, Michaelis S, (2009) ZMPSTE24, an integral membrane zinc metalloprotease with a connection to progeroid disorders. Biol Chem 390: 761-773.
15. Dutour A, Roll P, Gaborit B, Courrier S, Alessi MC, et al. (2011) High prevalence of laminopathies among patients with metabolic syndrome. Hum Mol Genet 20: 3779-3786.
16. Agarwal AK, Fryns JP, Auchus RJ, Garg A, (2003) Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12: 1995-2001.
17. Capell BC, Collins FS, (2006) Human laminopathies: nuclei gone genetically awry. Nat Rev Genet 7: 940-952.
18. Moulson CL, Go G, Gardner JM, van der Wal AC, Smitt JH, et al. (2005) Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J Invest Dermatol 125: 913-919.
19. Navarro CL, Cadinanos J, De Sandre-Giovannoli A, Bernard R, Courrier S, et al. (2005) Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum Mol Genet 14: 1503-1513.
20. Capell BC, Collins FS, Nabel EG, (2007) Mechanisms of cardiovascular disease in accelerated aging syndromes. Circ Res 101: 13-26.
21. Scaffidi P, Gordon L, Misteli T, (2005) The cell nucleus and aging: tantalizing clues and hopeful promises. PLoS Biol 3: e395.
22. Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, et al. (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358: 592-604.
23. Caron M, Auclair M, Donadille B, Bereziat V, Guerci B, et al. (2007) Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ 14: 1759-1767.
24. Caron M, Auclair M, Sterlingot H, Kornprobst M, Capeau J, (2003) Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. Aids 17: 2437-2444.
25. Coffinier C, Hudon SE, Farber EA, Chang SY, Hrycyna CA, et al. (2007) HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Proc Natl Acad Sci U S A 104: 13432-13437.
26. Hudon SE, Coffinier C, Michaelis S, Fong LG, Young SG, et al. (2008) HIV-protease inhibitors block the enzymatic activity of purified Ste24p. Biochem Biophys Res Commun 374: 365-368.
27. Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, et al. (2010) Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121: 2200-2210.
28. Holtz D, Tanaka RA, Hartwig J, McKeon F, (1989) The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope. Cell 59: 969-977.
29. Mallampalli MP, Huyer G, Bendale P, Gelb MH, Michaelis S, (2005) Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 102: 14416-14421.
30. Glynn MW, Glover TW, (2005) Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet 14: 2959-2969.
31. Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, et al. (2005) Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci U S A 102: 10291-10296.
32. Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, et al. (2005) Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 102: 12879-12884.
33. Corrigan DP, Kuszczak D, Rusinol AE, Thewke DP, Hrycyna CA, et al. (2005) Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem J 387: 129-138.
34. Barton RM, Worman HJ, (1999) Prenylated prelamin A interacts with Narf, a novel nuclear protein. J Biol Chem 274: 30008-30018.
35. Hennekes H, Nigg EA, (1994) The role of isoprenylation in membrane attachment of nuclear lamins. A single point mutation prevents proteolytic cleavage of the lamin A precursor and confers membrane binding properties. J Cell Sci 107 (Pt 4): 1019-1029.
36. Genschel J, Bochow B, Kuepferling S, Ewert R, Hetzer R, et al. (2001) A R644C mutation within lamin A extends the mutations causing dilated cardiomyopathy. Hum Mutat 17: 154.
37. Rankin J, Auer-Grumbach M, Bagg W, Colclough K, Nguyen TD, et al. (2008) Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C. Am J Med Genet A 146A: 1530-1542.
38. Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, et al. (2004) Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet 41: 304-308.
39. Worman HJ, Bonne G, (2007) "Laminopathies": a wide spectrum of human diseases. Exp Cell Res 313: 2121-2133.
40. Worman HJ, Fong LG, Muchir A, Young SG, (2009) Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119: 1825-1836.
41. Rodriguez S, Eriksson M, (2010) Evidence for the involvement of lamins in aging. Curr Aging Sci 3: 81-89.
42. Smigiel R, Jakubiak A, Esteves-Vieira V, Szela K, Halon A, et al. (2010) Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature. Am J Med Genet A 152A: 447-452.
43. Ben Yaou R, Navarro C, Quijano-Roy S, Bertrand AT, Massart C, et al. (2011) Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation. Eur J Hum Genet 19: 647-654.
44. Moulson CL, Fong LG, Gardner JM, Farber EA, Go G, et al. (2007) Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes. Hum Mutat 28: 882-889.
45. Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, et al. (2004) Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 13: 2493-2503.
46. Kieran MW, Gordon L, Kleinman M, (2007) New approaches to progeria. Pediatrics 120: 834-841.
47. Mercuri E, Brown SC, Nihoyannopoulos P, Poulton J, Kinali M, et al. (2005) Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve 31: 602-609.
48. Bergo MO, Leung GK, Ambroziak P, Otto JC, Casey PJ, et al. (2001) Isoprenylcysteine carboxyl methyltransferase deficiency in mice. J Biol Chem 276: 5841-5845.
49. Kim E, Ambroziak P, Otto JC, Taylor B, Ashby M, et al. (1999) Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells. J Biol Chem 274: 8383-8390.